--RBC Cuts Price Target on AdaptHealth to $18 From $24 After Q1 Miss, Notes Unexpected Weakness in Diabetes, Keeps Outperform Rating

--RBC Cuts Price Target on AdaptHealth to $18 From $24 After Q1 Miss, Notes Unexpected Weakness in Diabetes, Keeps Outperform Rating

MT Newswires · 05/11/2023 03:42

Please log in to view news